Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

S&P 500 EW Industrials Invesco ETF (RSPN)

S&P 500 EW Industrials Invesco ETF (RSPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Are Wall Street Analysts Predicting IDEX Stock Will Climb or Sink?

IDEX Corporation underperformed the broader market over the past year, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

IEX : 219.00 (+1.37%)
$SPX : 5,712.69 (-0.28%)
RSPN : 51.07 (-0.16%)
Do Wall Street Analysts Like Verisk Analytics Stock?

As Verisk Analytics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

VRSK : 277.22 (+0.63%)
$SPX : 5,712.69 (-0.28%)
RSPN : 51.07 (-0.16%)
Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot

These three equally-weighted exchange traded funds that offer superior diversification and risk adjusted returns are worth a look.

EQWL : 101.63 (-0.33%)
QQEW : 124.75 (+0.06%)
RSPN : 51.07 (-0.16%)
AAPL : 222.01 (-0.40%)
MSFT : 408.46 (-0.47%)
GOOGL : 169.24 (-1.20%)
NVDA : 136.05 (+0.48%)
META : 560.68 (-1.14%)
TSLA : 242.84 (-2.47%)
PDD : 122.32 (+1.46%)
AMGN : 316.91 (-0.72%)
CEG : 225.95 (-12.46%)

Barchart Exclusives

Is This High-Yield Dividend Stock a Buy After Earnings?
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar